Stock comparison

RGCvsZTS

Regencell Bioscience Holdings LtdvsZoetis Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

RGC

Regencell Bioscience Holdings Ltd

$28.31

+70.54%

Pharmaceuticals$11.9BNASDAQ

ZTS

Zoetis Inc

$116.06

-2.19%

Pharmaceuticals$48.8BNYSE

60-day price, rebased to 100

RGC -12.33% · ZTS -4.81%

Round-by-round

RGC 1·ZTS 3· 2ties

Tie

Valuation upside

— vs -36.20% to DCF fair value

EdgeRGC

Balance-sheet strength

Altman Z 32636.93 vs 5.39

EdgeZTS

Fundamental quality

Piotroski 4.00 vs 6.00 (of 9)

Tie

Growth + margins

Rule-of-40 — vs 26.40

EdgeZTS

60-day momentum

-12.33% vs -4.81% price return

EdgeZTS

Market-cap liquidity

$11.9B vs $48.8B

Verdict

Across6categories,ZTStakes the edge with3wins to1 (and 2 ties). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onRGCorZTS

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.